BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas.
BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas.
复制标题
BOLD 异步阐明了 IDH 突变神经胶质瘤的肿瘤负荷。
DOI:
10.1093/neuonc/noab154
复制
发表时间:
2022
期刊:
影响因子:
15.9
通讯作者:
Grinband,Jack
中科院分区:
文献类型:
--
作者:
Petridis,PetrosD;Horenstein,CraigI;Pereira,Brianna;Wu,PeterB;Samanamud,Jorge;Marie,Tamara;Boyett,Deborah;Sudhakar,TejaswiD;Sheth,SameerA;McKhann,GuyM;Sisti,MichaelB;Bruce,JeffreyN;Canoll,Peter;Grinband,Jack
BackgroundGliomas comprise the most common type of primary brain tumor, are highly invasive, and often fatal. IDH-mutated gliomas are particularly challenging to image and there is currently no clinically accepted method for identifying the extent of tumor burden in these neoplasms. This uncertainty poses a challenge to clinicians who must balance the need to treat the tumor while sparing healthy brain from iatrogenic damage. The purpose of this study was to investigate the feasibility of using resting-state blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) to detect glioma-related asynchrony in vascular dynamics for distinguishing tumor from healthy brain.MethodsTwenty-four stereotactically localized biopsies were obtained during open surgical resection from ten treatment-naïve patients with IDH-mutated gliomas who received standard-of-care preoperative imaging as well as echo-planar resting-state BOLD fMRI. Signal intensity for BOLD asynchrony and standard-of-care imaging was compared to cell counts of total cellularity (H&E), tumor density (IDH1 & Sox2), cellular proliferation (Ki67), and neuronal density (NeuN), for each corresponding sample.ResultsBOLD asynchrony was directly related to total cellularity (H&E,P= 4 × 10–5), tumor density (IDH1,P= 4 × 10–5; Sox2,P= 3 × 10–5), cellular proliferation (Ki67,P= .002), and inversely related to neuronal density (NeuN,P= 1 × 10–4).ConclusionsAsynchrony in vascular dynamics, as measured by resting-state BOLD fMRI, correlates with tumor burden and provides a radiographic delineation of tumor boundaries in IDH-mutated gliomas.